logo

For the Inventor, By the Inventor

Paris, France

Pharmaleads


USPTO Granted Patents = 12

% Expired Patents = 8.3



Trademarks = 2

Forward Citations = 53

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Marie-Claude Fournie-Zaluski (7 out of 20 patents)

silverMedal Bernard P Roques (7 out of 29 patents)

bronzeMedal Hervé Poras (6 out of 7 patents)

4.  Michel Wurm (3 out of 4 patents)

5.  Stéphane Melik Parsadaniantz (2 out of 2 patents)

6.  Annabelle Reaux-Le Goazigo (2 out of 2 patents)

7.  Hervé Poras (2 out of 4 patents)

8.  Jean-Baptiste Michel (1 out of 3 patents)

9.  Loic Lefebvre (1 out of 1 patent)

10.  Xinjun Zhao (1 out of 4 patents)

11.  Luca Gamberoni (1 out of 1 patent)

12.  Sabrina De Rosa (1 out of 1 patent)

13.  Rosario Velardi (1 out of 2 patents)

14.  François Rouzet (1 out of 2 patents)

15.  Dominique Leguludec (1 out of 1 patent)


12 patents:

1. 11648231 - Amino acid derivatives containing a disulfanyl group in the form of an NEP and APN inhibitor for the prevention and treatment of trigeminal nerve pain (2023-05-16),
2. 11090317 - Aminophosphinic derivatives for preventing and treating eye inflammation (2021-08-17),
3. 10688113 - Methods of treating eye pain with aminophosphinic derivatives (2020-06-23),
4. 10399936 - Industrial process for the preparation of (5S, 10S)-10-benzyl-16-methyl-11, 14, 18-trioxo-15, 17, 19-trioxa-2,7,8-trithia-12-azahenicosan-5-aminium(E)-3-carboxyacrylate salt (2019-09-03),
5. 10131681 - Aminophosphinic derivatives that can be used in the treatment of pain (2018-11-20),
6. 9388129 - Mixed inhibitors of aminopeptidase N and neprilysin (2016-07-12),
7. 9272054 - Agents for the molecular imaging of serine-protease in human pathologies (2016-03-01),
8. 8703747 - Aminophosphinic derivatives that can be used in the treatment of pain (2014-04-22),
9. 8247609 - Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase N inhibitors (2012-08-21),
10. 8247608 - Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase N inhibitors (2012-08-21),
11. 7875436 - Peptide substrates recognizable by a botulinum toxin A, BoNT/A and the use thereof (2011-01-25),
12. 6324785 - Process for harvesting organic compounds from plant roots (2001-12-04),
Pharmaleads is a biotechnology company specializing in the development of innovative pain management therapies. With a focus on non-opioid alternatives, Pharmaleads is dedicated to improving patient outcomes and reducing the opioid epidemic. Through cutting-edge research and strategic partnerships, Pharmaleads is at the forefront of the pain management industry.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Pharmaleads
12 Patents

#327 in Paris

#1,481 in France

#48,090 in the World

Paris, FR
Paris, France

Pharmaleads

Forward Citations = 53

18 inventors:

goldMedal Marie-Claude Fournie-Zaluski (7 out of 20 patents)

silverMedal Bernard P Roques (7 out of 29 patents)

bronzeMedal Hervé Poras (6 out of 7 patents)

4.  Michel Wurm (3 out of 4 patents)

5.  Stéphane Melik Parsadaniantz (2 out of 2 patents)

Please report any incorrect information to [email protected]
Loading…